tiprankstipranks
QuidelOrtho sees cost-savings of at least $50M in 2H24
The Fly

QuidelOrtho sees cost-savings of at least $50M in 2H24

Sees 2H and FY24 positive adjusted free cash flow to exceed 50% of adjusted EBITDA, including full year interest expense of $160M-$165M and CapEx of ~$170M, excluding reagent rentals.

Don't Miss our Black Friday Offers:

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App